Skip to main content
Log in

Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Gopal V, Bisno AL, Silverblatt FJ (1976) Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA 236:1604–1606

    Article  PubMed  CAS  Google Scholar 

  2. Rotun SS, McMath V, Schoonmaker DJ, Maupin PS, Tenover FC, Hill BC, Ackman DM (1999) Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 5:147–149

    Article  PubMed  CAS  Google Scholar 

  3. Moore MR, Perdreau-Remington F, Chambers HF (2003) Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 47:1262–1266

    Article  PubMed  CAS  Google Scholar 

  4. Howden BP, Ward PB, Charles PGP, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PDR, Morris AJ, Mayall BC, Grayson ML (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38:521–528

    Article  PubMed  CAS  Google Scholar 

  5. Leung KT, Tong MK, Siu YP, Lam CS, Ng HL, Lee HK (2004) Treatment of vancomycin-intermediate Staphylococcus aureus endocarditis with linezolid. Scand J Infect Dis 36:483–485

    Article  PubMed  CAS  Google Scholar 

  6. Bannerman TL (2003) Staphylococci, micrococci and other catalase-positive cocci that grow aerobically In: Murray PR, Baron EJ, Jorgensen SH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington, DC, pp 384–404

    Google Scholar 

  7. National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing, fourteenth informational supplement M100-S14. NCCLS, Wayne, PA

  8. Louie L, Matsumura SO, Choi E, Louie M, Simor AE (2000) Evaluation of three rapid methods for detection of methicillin-resistance in Staphylococcus aureus. J Clin Microbiol 38: 2170–2173

    PubMed  CAS  Google Scholar 

  9. Liu C, Chambers HF (2003) Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47:3040–3045

    Article  PubMed  CAS  Google Scholar 

  10. Kaatz G, Seo SM, Dorman NJ, Lerner SA (1990) Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 162:103–108

    PubMed  CAS  Google Scholar 

  11. Brunet F, Vedel G, Dreyfus F, Vaxelaire JF, Giraud T, Schremmer B, Monsallier JF (1990) Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur J Clin Microbiol Infect Dis 9:145–147

    Article  PubMed  CAS  Google Scholar 

  12. Shlaes DM, Slaes JH, Vincent S, Etter L, Fey PD, Goering RV (1993) Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob Agents Chemother 37:2432–2437

    PubMed  CAS  Google Scholar 

  13. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus in clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199–209

    Article  PubMed  CAS  Google Scholar 

  14. El Solh N, Davi M, Morvan A, Damon HA, Marty N, GISA group, RAISIN subgroup (2003) Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides. J Antimicrob Chemother 52:691–694

    Article  PubMed  CAS  Google Scholar 

  15. MacKenzie F, Greig P, Morrison D, Edwards G, Gould IM (2002) Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. J Antimicrob Chemother 50:689–697

    Article  PubMed  CAS  Google Scholar 

  16. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP (2002) A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother 50:171–175

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Giamarellou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Souli, M., Pontikis, K., Chryssouli, Z. et al. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid. Eur J Clin Microbiol Infect Dis 24, 760–762 (2005). https://doi.org/10.1007/s10096-005-0023-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-005-0023-9

Keywords

Navigation